stella
beta
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants — Stella
Recruiting
Back to Cystic Fibrosis trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Altasciences - Kansas City, Overland Park, Kansas
View full record on ClinicalTrials.gov